Tapewire

NYSE · USD

PG

PROCTER & GAMBLE Co

Export transactions ↓
Tapewire entity
2814
SEC CIK
0000080424
Parsed reports
3,815

Last 12 months

Inside the activity.

0 purchase rows · 31 sale rows

Disclosed non-derivative P/S rows, by transaction month. Includes amendments and private transactions.
Monthly counts
MonthPurchasesSales
Nov 202501
Dec 202500
Jan 202601
Feb 2026011
Mar 202600
Apr 202600
May 202600
Jun 202600
Jul 202600
Aug 2026015
Sep 202600
Oct 202603

Latest available

Insider transactions

JSON API
Reset

Purchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”

The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.

Transaction dateOwner / reported roleActivity / securityShares / unitsReported priceReported valueDetails
May 17, 2021 Filed Aug 4, 2021 15:12 UTC
Grabowski Mary TheresaChief Human Resources Officer
GrantRestricted Stock Units · Derivative 6.5665 $0.00 $0.00
Disclosure

SEC source: 0001127602-21-023026 · form4.xml · derivative · entry 6

Grabowski Mary Theresa · CIK 0001747030 · Chief Human Resources Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 31.2516

Underlying: Common Stock · 6.5665 shares

Expires not disclosed

F3 · derivative.exercise_price: Dividend equivalents in the form of Restricted Stock Units (RSUs) previously awarded pursuant to issuer's retirement program. All such RSUs represent a contingent right to receive Procter & Gamble common stock.

F4 · derivative.exercise_date: These units will deliver in shares on retirement from the company, unless delivery is deferred or such shares are contributed to reporting person's deferred compensation account.

F4 · derivative.expiration_date: These units will deliver in shares on retirement from the company, unless delivery is deferred or such shares are contributed to reporting person's deferred compensation account.

Read SEC document
May 17, 2021 Filed Aug 4, 2021 15:17 UTC
Jejurikar ShaileshCEO - Fabric & Home Care
GrantRestricted Stock Units · Derivative 15.6878 $0.00 $0.00
Disclosure

SEC source: 0001127602-21-023028 · form4.xml · derivative · entry 7

Jejurikar Shailesh · CIK 0001746310 · CEO - Fabric & Home Care

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 149.5439

Underlying: Common Stock · 15.6878 shares

Expires not disclosed

F4 · derivative.exercise_price: Dividend equivalents in the form of Restricted Stock Units (RSUs) previously awarded pursuant to issuer's retirement program. All such RSUs represent a contingent right to receive Procter & Gamble common stock.

F5 · derivative.exercise_date: These units will deliver in shares on retirement from the company, unless delivery is deferred or such shares are contributed to reporting person's deferred compensation account.

F5 · derivative.expiration_date: These units will deliver in shares on retirement from the company, unless delivery is deferred or such shares are contributed to reporting person's deferred compensation account.

Read SEC document
May 17, 2021 Filed Aug 4, 2021 15:19 UTC
Keith R. AlexandraCEO - Beauty
GrantRestricted Stock Units · Derivative 28.4559 $0.00 $0.00
Disclosure

SEC source: 0001127602-21-023029 · form4.xml · derivative · entry 5

Keith R. Alexandra · CIK 0001710268 · CEO - Beauty

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 327.2852

Underlying: Common Stock · 28.4559 shares

Expires not disclosed

F4 · derivative.exercise_price: Dividend equivalents in the form of Restricted Stock Units (RSUs) previously awarded pursuant to issuer's retirement program. All such RSUs represent a contingent right to receive Procter & Gamble common stock.

F5 · derivative.exercise_date: These units will deliver in shares on retirement from the company, unless delivery is deferred or such shares are contributed to reporting person's deferred compensation account.

F5 · derivative.expiration_date: These units will deliver in shares on retirement from the company, unless delivery is deferred or such shares are contributed to reporting person's deferred compensation account.

Read SEC document
May 17, 2021 Filed Aug 5, 2021 13:03 UTC
FergusonMchugh MaryLynnCEO - Family Care & P&G Ventur
GrantRestricted Stock Units · Derivative 116.4526 $0.00 $0.00
Disclosure

SEC source: 0001127602-21-023134 · form4.xml · derivative · entry 6

FergusonMchugh MaryLynn · CIK 0001613133 · CEO - Family Care & P&G Ventur

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 2,212.9419

Underlying: Common Stock · 116.4526 shares

Expires not disclosed

F4 · derivative.exercise_price: Dividend equivalents in the form of Restricted Stock Units (RSUs) previously awarded pursuant to issuer's retirement program. All such RSUs represent a contingent right to receive Procter & Gamble common stock.

F5 · derivative.exercise_date: These units will deliver in shares on retirement from the company, unless delivery is deferred or such shares are contributed to reporting person's deferred compensation account.

F5 · derivative.expiration_date: These units will deliver in shares on retirement from the company, unless delivery is deferred or such shares are contributed to reporting person's deferred compensation account.

Read SEC document
May 17, 2021 Filed Aug 9, 2021 20:26 UTC
Moeller Jon RVice Chairman and COO
GrantRestricted Stock Units · Derivative 135.7247 $0.00 $0.00
Disclosure

SEC source: 0001127602-21-023350 · form4.xml · derivative · entry 5

Moeller Jon R · CIK 0001450613 · Vice Chairman and COO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 3,792.2212

Underlying: Common Stock · 135.7247 shares

Expires not disclosed

F3 · derivative.exercise_price: Dividend equivalents in the form of Restricted Stock Units (RSUs) previously awarded pursuant to issuer's retirement program. All such RSUs represent a contingent right to receive Procter & Gamble common stock.

F4 · derivative.exercise_date: These units will deliver in shares on retirement from the company, unless delivery is deferred or such shares are contributed to reporting person's deferred compensation account.

F4 · derivative.expiration_date: These units will deliver in shares on retirement from the company, unless delivery is deferred or such shares are contributed to reporting person's deferred compensation account.

Read SEC document
May 17, 2021 Filed Aug 9, 2021 20:28 UTC
Majoras Deborah PChief Legal Officer & Secy
GrantRestricted Stock Units · Derivative 76.1531 $0.00 $0.00
Disclosure

SEC source: 0001127602-21-023353 · form4.xml · derivative · entry 3

Majoras Deborah P · CIK 0001483177 · Chief Legal Officer & Secy

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 1,871.6207

Underlying: Common Stock · 76.1531 shares

Expires not disclosed

F3 · derivative.exercise_price: Dividend equivalents in the form of Restricted Stock Units (RSUs) previously awarded pursuant to issuer's retirement program. All such RSUs represent a contingent right to receive Procter & Gamble common stock.

F4 · derivative.exercise_date: These units will deliver in shares on retirement from the company, unless delivery is deferred or such shares are contributed to reporting person's deferred compensation account.

F4 · derivative.expiration_date: These units will deliver in shares on retirement from the company, unless delivery is deferred or such shares are contributed to reporting person's deferred compensation account.

Read SEC document
May 17, 2021 Filed Aug 9, 2021 23:57 UTC
Pritchard Marc S.Chief Brand Officer
GrantRestricted Stock Units · Derivative 170.917 $0.00 $0.00
Disclosure

SEC source: 0001127602-21-023400 · form4.xml · derivative · entry 8

Pritchard Marc S. · CIK 0001440364 · Chief Brand Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 5,490.7317

Underlying: Common Stock · 170.917 shares

Expires not disclosed

F3 · derivative.exercise_price: Dividend equivalents in the form of Restricted Stock Units (RSUs) previously awarded pursuant to issuer's retirement program. All such RSUs represent a contingent right to receive Procter & Gamble common stock.

F4 · derivative.exercise_date: These units will deliver in shares on retirement from the company, unless delivery is deferred or such shares are contributed to reporting person's deferred compensation account.

F4 · derivative.expiration_date: These units will deliver in shares on retirement from the company, unless delivery is deferred or such shares are contributed to reporting person's deferred compensation account.

Read SEC document
May 12, 2021 Filed May 13, 2021 20:21 UTC
Schulten AndreChief Financial Officer
Exercise / conversionStock Option (Right to Buy) · Derivative 22,952 $0.00 Strike: $67.52 $0.00
Disclosure

SEC source: 0001127602-21-016568 · form4.xml · derivative · entry 5

Schulten Andre · CIK 0001844763 · Chief Financial Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 0

Underlying: Common Stock · 22,952 shares

Expires 2022-02-28

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

Read SEC document
May 12, 2021 Filed May 13, 2021 20:21 UTC
Schulten AndreChief Financial Officer
SaleCommon Stock 22,952 $136.46 $3,132,029.92
Disclosure

SEC source: 0001127602-21-016568 · form4.xml · nonDerivative · entry 3

Schulten Andre · CIK 0001844763 · Chief Financial Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 22,820.196

Read SEC document
May 12, 2021 Filed May 13, 2021 20:21 UTC
Schulten AndreChief Financial Officer
Exercise / conversionCommon Stock 22,952 $67.52 $1,549,719.04
Disclosure

SEC source: 0001127602-21-016568 · form4.xml · nonDerivative · entry 2

Schulten Andre · CIK 0001844763 · Chief Financial Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 45,772.196

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

Read SEC document
May 12, 2021 Filed May 13, 2021 20:21 UTC
Schulten AndreChief Financial Officer
SaleCommon Stock 1,458 $136.12 $198,464.71
Disclosure

SEC source: 0001127602-21-016568 · form4.xml · nonDerivative · entry 1

Schulten Andre · CIK 0001844763 · Chief Financial Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 22,820.196

F1 · price: Weighted average price of the shares sold. The price range was $136.10 to $136.13. Full information regarding the number of shares sold at each separate price available upon request.

Read SEC document
May 11, 2021 Filed May 13, 2021 20:17 UTC
Bishop Steven DCEO - Health Care
Exercise / conversionStock Option (Right to Buy) · Derivative 60,000 $0.00 Strike: $78.66 $0.00
Disclosure

SEC source: 0001127602-21-016562 · form4.xml · derivative · entry 5

Bishop Steven D · CIK 0001669212 · CEO - Health Care

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 39,797

Underlying: Common Stock · 60,000 shares

Expires 2024-02-28

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

Read SEC document
May 11, 2021 Filed May 13, 2021 20:17 UTC
Bishop Steven DCEO - Health Care
SaleCommon Stock 60,000 $138.50 $8,310,000.00
Disclosure

SEC source: 0001127602-21-016562 · form4.xml · nonDerivative · entry 2

Bishop Steven D · CIK 0001669212 · CEO - Health Care

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 58,677.8862

Read SEC document
May 11, 2021 Filed May 13, 2021 20:17 UTC
Bishop Steven DCEO - Health Care
Exercise / conversionCommon Stock 60,000 $78.66 $4,719,600.00
Disclosure

SEC source: 0001127602-21-016562 · form4.xml · nonDerivative · entry 1

Bishop Steven D · CIK 0001669212 · CEO - Health Care

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 118,677.8862

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

Read SEC document
May 11, 2021 Filed May 13, 2021 20:19 UTC
TASTAD CAROLYN MGroup Pres-Chief Sales Officer
SaleCommon Stock 3,513 $137.27 $482,242.86
Disclosure

SEC source: 0001127602-21-016564 · form4.xml · nonDerivative · entry 1

TASTAD CAROLYN M · CIK 0001597938 · Group Pres-Chief Sales Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 38,935.7086

Read SEC document
May 11, 2021 Filed May 13, 2021 20:23 UTC
Taylor David SDirector · Chairman, President & CEO
Exercise / conversionStock Option (Right to Buy) · Derivative 55,000 $0.00 Strike: $85.13 $0.00
Disclosure

SEC source: 0001127602-21-016570 · form4.xml · derivative · entry 4

Taylor David S · CIK 0001505989 · Director · Chairman, President & CEO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 56,202

Underlying: Common Stock · 55,000 shares

Expires 2025-02-27

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

Read SEC document
May 11, 2021 Filed May 13, 2021 20:23 UTC
Taylor David SDirector · Chairman, President & CEO
SaleCommon Stock 55,000 $138.25 $7,603,475.00
Disclosure

SEC source: 0001127602-21-016570 · form4.xml · nonDerivative · entry 2

Taylor David S · CIK 0001505989 · Director · Chairman, President & CEO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 240,287.8142

F1 · price: Weighted average price of the shares sold. The price range was $138.32 to $138.20. Full information regarding the number of shares sold at each separate price available upon request.

Read SEC document
May 11, 2021 Filed May 13, 2021 20:23 UTC
Taylor David SDirector · Chairman, President & CEO
Exercise / conversionCommon Stock 55,000 $85.13 $4,682,150.00
Disclosure

SEC source: 0001127602-21-016570 · form4.xml · nonDerivative · entry 1

Taylor David S · CIK 0001505989 · Director · Chairman, President & CEO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 295,287.8142

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

Read SEC document
May 10, 2021 Filed May 11, 2021 17:26 UTC
Coombe Gary ACEO - Grooming
SaleCommon Stock 4,500 $137.91 $620,608.95
Disclosure

SEC source: 0001127602-21-016179 · form4.xml · nonDerivative · entry 2

Coombe Gary A · CIK 0001623622 · CEO - Grooming

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 4,511

F1 · price: Weighted average price of the shares sold. The price range was $137.90 to $137.93. Full information regarding the number of shares sold at each separate price available upon request.

Read SEC document
May 07, 2021 Filed May 10, 2021 20:19 UTC
Taylor David SDirector · Chairman, President & CEO
Exercise / conversionStock Option (Right to Buy) · Derivative 68,275 $0.00 Strike: $69.45 $0.00
Disclosure

SEC source: 0001127602-21-016048 · form4.xml · derivative · entry 4

Taylor David S · CIK 0001505989 · Director · Chairman, President & CEO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 0

Underlying: Common Stock · 68,275 shares

Expires 2025-09-15

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

Read SEC document
May 07, 2021 Filed May 10, 2021 20:19 UTC
Taylor David SDirector · Chairman, President & CEO
SaleCommon Stock 68,275 $135.47 $9,249,262.04
Disclosure

SEC source: 0001127602-21-016048 · form4.xml · nonDerivative · entry 2

Taylor David S · CIK 0001505989 · Director · Chairman, President & CEO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 240,287.8142

F1 · price: Weighted average price of the shares sold. The price range was $135.23 to $135.74. Full information regarding the number of shares sold at each separate price available upon request.

Read SEC document
May 07, 2021 Filed May 10, 2021 20:19 UTC
Taylor David SDirector · Chairman, President & CEO
Exercise / conversionCommon Stock 68,275 $69.45 $4,741,698.75
Disclosure

SEC source: 0001127602-21-016048 · form4.xml · nonDerivative · entry 1

Taylor David S · CIK 0001505989 · Director · Chairman, President & CEO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 308,562.8142

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

Read SEC document
May 06, 2021 Filed May 7, 2021 01:54 UTC
PELTZ NELSONDirector
OtherCommon Stock 329,929 $135.14 $44,586,605.06
Disclosure

SEC source: 0001209191-21-030779 · doc4.xml · nonDerivative · entry 6

PELTZ NELSON · CIK 0000928265 · Director

TRIAN FUND MANAGEMENT, L.P. · CIK 0001345471 · Director

Joint disclosure: these amounts are not allocated separately to each reporting owner.

10b5-1 filing: Not disclosed

Ownership: Indirect · Please see explanation below

Disclosed balance after: 5,786,361

F9 · kind: Represents a distribution of shares to the limited partner in the parent entity of a Trian Entity in connection with the winding down of such Trian Entity.

F3 · ownership.nature: Trian Fund Management, L.P. ("Trian Management") serves as the management company for Trian Partners, L.P., Trian Partners Master Fund, L.P., Trian Partners Parallel Fund I, L.P., Trian Partners Strategic Investment Fund-A, L.P., Trian Partners Strategic Co-Investment Fund-A, L.P., Trian Partners Strategic Investment Fund-N, L.P., Trian Partners Strategic Investment Fund-D, L.P., Trian Partners Fund (Sub)-G, L.P., Trian Partners Strategic Fund-G II, L.P., Trian Partners Strategic Fund G-III, L.P., Trian Partners Strategic Fund-K, L.P., Trian Partners Strategic Fund-C, Ltd., and Trian Partners Co-Investment Opportunities Fund, Ltd. (collectively, the "Trian Entities") and as such determines the investment and voting decisions of the Trian Entities with respect to the shares of the Issuer held by them.

F4 · ownership.nature: (FN 3, contd.) Mr. Peltz is a member of Trian Fund Management GP, LLC, which is the general partner of Trian Management, and therefore is in a position to determine the investment and voting decisions made by Trian Management on behalf of the Trian Entities. Accordingly, Mr. Peltz and Trian Management may be deemed to indirectly beneficially own (as that term is defined in Rule 13d-3 under the Securities Exchange Act of 1934) the shares beneficially owned by the Trian Entities. The Reporting Persons disclaim beneficial ownership of such shares except to the extent of their respective pecuniary interests therein and this report shall not be deemed an admission that the Reporting Persons are the beneficial owner of such securities for purposes of Section 16 or for any other purpose. Mr. Peltz is a director of the Issuer.

Read SEC document
May 06, 2021 Filed May 7, 2021 01:54 UTC
PELTZ NELSONDirector
SaleCommon Stock 6,000 $135.01 $810,072.00
Disclosure

SEC source: 0001209191-21-030779 · doc4.xml · nonDerivative · entry 5

PELTZ NELSON · CIK 0000928265 · Director

TRIAN FUND MANAGEMENT, L.P. · CIK 0001345471 · Director

Joint disclosure: these amounts are not allocated separately to each reporting owner.

10b5-1 filing: Not disclosed

Ownership: Indirect · Please see explanation below

Disclosed balance after: 6,116,290

F1 · kind: Represents the sales of shares in connection with the expiration of the applicable lock-up periods of two Trian Entities (as defined below) holding shares of the Issuer.

F8 · price: The price shown in Column 4 is a weighted average sale price. The price range for the sale is $134.995 to $135.015. The Reporting Persons undertake to provide upon request by the staff of the Securities and Exchange Commission, the Issuer or a security holder of the Issuer, full information regarding the number of shares sold at each separate price.

F3 · ownership.nature: Trian Fund Management, L.P. ("Trian Management") serves as the management company for Trian Partners, L.P., Trian Partners Master Fund, L.P., Trian Partners Parallel Fund I, L.P., Trian Partners Strategic Investment Fund-A, L.P., Trian Partners Strategic Co-Investment Fund-A, L.P., Trian Partners Strategic Investment Fund-N, L.P., Trian Partners Strategic Investment Fund-D, L.P., Trian Partners Fund (Sub)-G, L.P., Trian Partners Strategic Fund-G II, L.P., Trian Partners Strategic Fund G-III, L.P., Trian Partners Strategic Fund-K, L.P., Trian Partners Strategic Fund-C, Ltd., and Trian Partners Co-Investment Opportunities Fund, Ltd. (collectively, the "Trian Entities") and as such determines the investment and voting decisions of the Trian Entities with respect to the shares of the Issuer held by them.

F4 · ownership.nature: (FN 3, contd.) Mr. Peltz is a member of Trian Fund Management GP, LLC, which is the general partner of Trian Management, and therefore is in a position to determine the investment and voting decisions made by Trian Management on behalf of the Trian Entities. Accordingly, Mr. Peltz and Trian Management may be deemed to indirectly beneficially own (as that term is defined in Rule 13d-3 under the Securities Exchange Act of 1934) the shares beneficially owned by the Trian Entities. The Reporting Persons disclaim beneficial ownership of such shares except to the extent of their respective pecuniary interests therein and this report shall not be deemed an admission that the Reporting Persons are the beneficial owner of such securities for purposes of Section 16 or for any other purpose. Mr. Peltz is a director of the Issuer.

Read SEC document
May 06, 2021 Filed May 7, 2021 01:54 UTC
PELTZ NELSONDirector
SaleCommon Stock 990,387 $134.63 $133,338,277.78
Disclosure

SEC source: 0001209191-21-030779 · doc4.xml · nonDerivative · entry 4

PELTZ NELSON · CIK 0000928265 · Director

TRIAN FUND MANAGEMENT, L.P. · CIK 0001345471 · Director

Joint disclosure: these amounts are not allocated separately to each reporting owner.

10b5-1 filing: Not disclosed

Ownership: Indirect · Please see explanation below

Disclosed balance after: 6,122,290

F1 · kind: Represents the sales of shares in connection with the expiration of the applicable lock-up periods of two Trian Entities (as defined below) holding shares of the Issuer.

F7 · price: The price shown in Column 4 is a weighted average sale price. The price range for the sale is $134.00 to $134.99. The Reporting Persons undertake to provide upon request by the staff of the Securities and Exchange Commission, the Issuer or a security holder of the Issuer, full information regarding the number of shares sold at each separate price.

F3 · ownership.nature: Trian Fund Management, L.P. ("Trian Management") serves as the management company for Trian Partners, L.P., Trian Partners Master Fund, L.P., Trian Partners Parallel Fund I, L.P., Trian Partners Strategic Investment Fund-A, L.P., Trian Partners Strategic Co-Investment Fund-A, L.P., Trian Partners Strategic Investment Fund-N, L.P., Trian Partners Strategic Investment Fund-D, L.P., Trian Partners Fund (Sub)-G, L.P., Trian Partners Strategic Fund-G II, L.P., Trian Partners Strategic Fund G-III, L.P., Trian Partners Strategic Fund-K, L.P., Trian Partners Strategic Fund-C, Ltd., and Trian Partners Co-Investment Opportunities Fund, Ltd. (collectively, the "Trian Entities") and as such determines the investment and voting decisions of the Trian Entities with respect to the shares of the Issuer held by them.

F4 · ownership.nature: (FN 3, contd.) Mr. Peltz is a member of Trian Fund Management GP, LLC, which is the general partner of Trian Management, and therefore is in a position to determine the investment and voting decisions made by Trian Management on behalf of the Trian Entities. Accordingly, Mr. Peltz and Trian Management may be deemed to indirectly beneficially own (as that term is defined in Rule 13d-3 under the Securities Exchange Act of 1934) the shares beneficially owned by the Trian Entities. The Reporting Persons disclaim beneficial ownership of such shares except to the extent of their respective pecuniary interests therein and this report shall not be deemed an admission that the Reporting Persons are the beneficial owner of such securities for purposes of Section 16 or for any other purpose. Mr. Peltz is a director of the Issuer.

Read SEC document
May 06, 2021 Filed May 10, 2021 13:13 UTC
Francisco Ma. FatimaCEO - Baby & Feminine Care
SaleCommon Stock 3,000 $135.00 $405,000.00
Disclosure

SEC source: 0001127602-21-015960 · form4.xml · nonDerivative · entry 1

Francisco Ma. Fatima · CIK 0001747222 · CEO - Baby & Feminine Care

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 11,085.48

Read SEC document
May 05, 2021 Filed May 7, 2021 01:54 UTC
PELTZ NELSONDirector
SaleCommon Stock 766,810 $134.30 $102,983,273.13
Disclosure

SEC source: 0001209191-21-030779 · doc4.xml · nonDerivative · entry 3

PELTZ NELSON · CIK 0000928265 · Director

TRIAN FUND MANAGEMENT, L.P. · CIK 0001345471 · Director

Joint disclosure: these amounts are not allocated separately to each reporting owner.

10b5-1 filing: Not disclosed

Ownership: Indirect · Please see explanation below

Disclosed balance after: 7,112,677

F1 · kind: Represents the sales of shares in connection with the expiration of the applicable lock-up periods of two Trian Entities (as defined below) holding shares of the Issuer.

F6 · price: The price shown in Column 4 is a weighted average sale price. The price range for the sale is $134.00 to $134.91. The Reporting Persons undertake to provide upon request by the staff of the Securities and Exchange Commission, the Issuer or a security holder of the Issuer, full information regarding the number of shares sold at each separate price.

F3 · ownership.nature: Trian Fund Management, L.P. ("Trian Management") serves as the management company for Trian Partners, L.P., Trian Partners Master Fund, L.P., Trian Partners Parallel Fund I, L.P., Trian Partners Strategic Investment Fund-A, L.P., Trian Partners Strategic Co-Investment Fund-A, L.P., Trian Partners Strategic Investment Fund-N, L.P., Trian Partners Strategic Investment Fund-D, L.P., Trian Partners Fund (Sub)-G, L.P., Trian Partners Strategic Fund-G II, L.P., Trian Partners Strategic Fund G-III, L.P., Trian Partners Strategic Fund-K, L.P., Trian Partners Strategic Fund-C, Ltd., and Trian Partners Co-Investment Opportunities Fund, Ltd. (collectively, the "Trian Entities") and as such determines the investment and voting decisions of the Trian Entities with respect to the shares of the Issuer held by them.

F4 · ownership.nature: (FN 3, contd.) Mr. Peltz is a member of Trian Fund Management GP, LLC, which is the general partner of Trian Management, and therefore is in a position to determine the investment and voting decisions made by Trian Management on behalf of the Trian Entities. Accordingly, Mr. Peltz and Trian Management may be deemed to indirectly beneficially own (as that term is defined in Rule 13d-3 under the Securities Exchange Act of 1934) the shares beneficially owned by the Trian Entities. The Reporting Persons disclaim beneficial ownership of such shares except to the extent of their respective pecuniary interests therein and this report shall not be deemed an admission that the Reporting Persons are the beneficial owner of such securities for purposes of Section 16 or for any other purpose. Mr. Peltz is a director of the Issuer.

Read SEC document
May 04, 2021 Filed May 7, 2021 01:54 UTC
PELTZ NELSONDirector
SaleCommon Stock 62,770 $135.29 $8,492,228.62
Disclosure

SEC source: 0001209191-21-030779 · doc4.xml · nonDerivative · entry 2

PELTZ NELSON · CIK 0000928265 · Director

TRIAN FUND MANAGEMENT, L.P. · CIK 0001345471 · Director

Joint disclosure: these amounts are not allocated separately to each reporting owner.

10b5-1 filing: Not disclosed

Ownership: Indirect · Please see explanation below

Disclosed balance after: 7,879,487

F1 · kind: Represents the sales of shares in connection with the expiration of the applicable lock-up periods of two Trian Entities (as defined below) holding shares of the Issuer.

F5 · price: The price shown in Column 4 is a weighted average sale price. The price range for the sale is $135.2450 to $135.42. The Reporting Persons undertake to provide upon request by the staff of the Securities and Exchange Commission, the Issuer or a security holder of the Issuer, full information regarding the number of shares sold at each separate price.

F3 · ownership.nature: Trian Fund Management, L.P. ("Trian Management") serves as the management company for Trian Partners, L.P., Trian Partners Master Fund, L.P., Trian Partners Parallel Fund I, L.P., Trian Partners Strategic Investment Fund-A, L.P., Trian Partners Strategic Co-Investment Fund-A, L.P., Trian Partners Strategic Investment Fund-N, L.P., Trian Partners Strategic Investment Fund-D, L.P., Trian Partners Fund (Sub)-G, L.P., Trian Partners Strategic Fund-G II, L.P., Trian Partners Strategic Fund G-III, L.P., Trian Partners Strategic Fund-K, L.P., Trian Partners Strategic Fund-C, Ltd., and Trian Partners Co-Investment Opportunities Fund, Ltd. (collectively, the "Trian Entities") and as such determines the investment and voting decisions of the Trian Entities with respect to the shares of the Issuer held by them.

F4 · ownership.nature: (FN 3, contd.) Mr. Peltz is a member of Trian Fund Management GP, LLC, which is the general partner of Trian Management, and therefore is in a position to determine the investment and voting decisions made by Trian Management on behalf of the Trian Entities. Accordingly, Mr. Peltz and Trian Management may be deemed to indirectly beneficially own (as that term is defined in Rule 13d-3 under the Securities Exchange Act of 1934) the shares beneficially owned by the Trian Entities. The Reporting Persons disclaim beneficial ownership of such shares except to the extent of their respective pecuniary interests therein and this report shall not be deemed an admission that the Reporting Persons are the beneficial owner of such securities for purposes of Section 16 or for any other purpose. Mr. Peltz is a director of the Issuer.

Read SEC document
May 04, 2021 Filed May 7, 2021 01:54 UTC
PELTZ NELSONDirector
SaleCommon Stock 937,230 $134.61 $126,161,654.98
Disclosure

SEC source: 0001209191-21-030779 · doc4.xml · nonDerivative · entry 1

PELTZ NELSON · CIK 0000928265 · Director

TRIAN FUND MANAGEMENT, L.P. · CIK 0001345471 · Director

Joint disclosure: these amounts are not allocated separately to each reporting owner.

10b5-1 filing: Not disclosed

Ownership: Indirect · Please see explanation below

Disclosed balance after: 7,942,257

F1 · kind: Represents the sales of shares in connection with the expiration of the applicable lock-up periods of two Trian Entities (as defined below) holding shares of the Issuer.

F2 · price: The price shown in Column 4 is a weighted average sale price. The price range for the sale is $134.25 to $135.24. The Reporting Persons undertake to provide upon request by the staff of the Securities and Exchange Commission, the Issuer or a security holder of the Issuer, full information regarding the number of shares sold at each separate price.

F3 · ownership.nature: Trian Fund Management, L.P. ("Trian Management") serves as the management company for Trian Partners, L.P., Trian Partners Master Fund, L.P., Trian Partners Parallel Fund I, L.P., Trian Partners Strategic Investment Fund-A, L.P., Trian Partners Strategic Co-Investment Fund-A, L.P., Trian Partners Strategic Investment Fund-N, L.P., Trian Partners Strategic Investment Fund-D, L.P., Trian Partners Fund (Sub)-G, L.P., Trian Partners Strategic Fund-G II, L.P., Trian Partners Strategic Fund G-III, L.P., Trian Partners Strategic Fund-K, L.P., Trian Partners Strategic Fund-C, Ltd., and Trian Partners Co-Investment Opportunities Fund, Ltd. (collectively, the "Trian Entities") and as such determines the investment and voting decisions of the Trian Entities with respect to the shares of the Issuer held by them.

F4 · ownership.nature: (FN 3, contd.) Mr. Peltz is a member of Trian Fund Management GP, LLC, which is the general partner of Trian Management, and therefore is in a position to determine the investment and voting decisions made by Trian Management on behalf of the Trian Entities. Accordingly, Mr. Peltz and Trian Management may be deemed to indirectly beneficially own (as that term is defined in Rule 13d-3 under the Securities Exchange Act of 1934) the shares beneficially owned by the Trian Entities. The Reporting Persons disclaim beneficial ownership of such shares except to the extent of their respective pecuniary interests therein and this report shall not be deemed an admission that the Reporting Persons are the beneficial owner of such securities for purposes of Section 16 or for any other purpose. Mr. Peltz is a director of the Issuer.

Read SEC document
May 03, 2021 Filed May 5, 2021 20:22 UTC
Moeller Jon RVice Chairman and COO
Exercise / conversionStock Option (Right to Buy) · Derivative 22,975 $0.00 Strike: $85.13 $0.00
Disclosure

SEC source: 0001127602-21-015528 · form4.xml · derivative · entry 8

Moeller Jon R · CIK 0001450613 · Vice Chairman and COO

10b5-1 filing: Not disclosed

Ownership: Indirect · By Spouse

Disclosed balance after: 0

Underlying: Common Stock · 22,975 shares

Expires 2025-02-27

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

Read SEC document
May 03, 2021 Filed May 5, 2021 20:22 UTC
Moeller Jon RVice Chairman and COO
Exercise / conversionStock Option (Right to Buy) · Derivative 132,151 $0.00 Strike: $85.13 $0.00
Disclosure

SEC source: 0001127602-21-015528 · form4.xml · derivative · entry 7

Moeller Jon R · CIK 0001450613 · Vice Chairman and COO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 0

Underlying: Common Stock · 132,151 shares

Expires 2025-02-27

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

Read SEC document
May 03, 2021 Filed May 5, 2021 20:22 UTC
Moeller Jon RVice Chairman and COO
SaleCommon Stock 22,975 $134.64 $3,093,264.40
Disclosure

SEC source: 0001127602-21-015528 · form4.xml · nonDerivative · entry 4

Moeller Jon R · CIK 0001450613 · Vice Chairman and COO

10b5-1 filing: Not disclosed

Ownership: Indirect · By Spouse

Disclosed balance after: 5,586.9821

F2 · price: Weighted average price of the shares sold. The price range was $134.62 to $134.70. Full information regarding the number of shares sold at each separate price available upon request.

Read SEC document
May 03, 2021 Filed May 5, 2021 20:22 UTC
Moeller Jon RVice Chairman and COO
Exercise / conversionCommon Stock 22,975 $85.13 $1,955,861.75
Disclosure

SEC source: 0001127602-21-015528 · form4.xml · nonDerivative · entry 3

Moeller Jon R · CIK 0001450613 · Vice Chairman and COO

10b5-1 filing: Not disclosed

Ownership: Indirect · By Spouse

Disclosed balance after: 28,561.9821

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

Read SEC document
May 03, 2021 Filed May 5, 2021 20:22 UTC
Moeller Jon RVice Chairman and COO
SaleCommon Stock 132,151 $134.61 $17,788,859.33
Disclosure

SEC source: 0001127602-21-015528 · form4.xml · nonDerivative · entry 2

Moeller Jon R · CIK 0001450613 · Vice Chairman and COO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 121,671.9888

F1 · price: Weighted average price of the shares sold. The price range was $134.25 to $135.03. Full information regarding the number of shares sold at each separate price available upon request.

Read SEC document
May 03, 2021 Filed May 5, 2021 20:22 UTC
Moeller Jon RVice Chairman and COO
Exercise / conversionCommon Stock 132,151 $85.13 $11,250,014.63
Disclosure

SEC source: 0001127602-21-015528 · form4.xml · nonDerivative · entry 1

Moeller Jon R · CIK 0001450613 · Vice Chairman and COO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 253,822.9888

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

Read SEC document
April 22, 2021 Filed Apr 23, 2021 15:34 UTC
Majoras Deborah PChief Legal Officer & Secy
SaleCommon Stock 12,872 $135.47 $1,743,769.84
Disclosure

SEC source: 0001127602-21-014321 · form4.xml · nonDerivative · entry 1

Majoras Deborah P · CIK 0001483177 · Chief Legal Officer & Secy

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 30,428.5832

Read SEC document
April 21, 2021 Filed Apr 22, 2021 18:44 UTC
Keith R. AlexandraCEO - Beauty
SaleCommon Stock 2,285 $137.99 $315,307.15
Disclosure

SEC source: 0001127602-21-014255 · form4.xml · nonDerivative · entry 2

Keith R. Alexandra · CIK 0001710268 · CEO - Beauty

10b5-1 filing: Not disclosed

Ownership: Indirect · By Spouse

Disclosed balance after: 5,733.2883

Read SEC document
April 21, 2021 Filed Apr 22, 2021 18:44 UTC
Keith R. AlexandraCEO - Beauty
SaleCommon Stock 10,383 $137.99 $1,432,750.17
Disclosure

SEC source: 0001127602-21-014255 · form4.xml · nonDerivative · entry 1

Keith R. Alexandra · CIK 0001710268 · CEO - Beauty

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 29,016.6703

Read SEC document
April 21, 2021 Filed Apr 22, 2021 19:23 UTC
Francisco Ma. FatimaCEO - Baby & Feminine Care
SaleCommon Stock 3,750 $137.14 $514,257.38
Disclosure

SEC source: 0001127602-21-014268 · form4.xml · nonDerivative · entry 1

Francisco Ma. Fatima · CIK 0001747222 · CEO - Baby & Feminine Care

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 14,085.48

F1 · balance_after: Total includes grant of dividend equivalents in the form of Restricted Stock Units (RSU's) settled in common stock.

Read SEC document
April 01, 2021 Filed Apr 1, 2021 19:28 UTC
Schulten AndreChief Financial Officer
SaleCommon Stock 571 $133.53 $76,243.29
Disclosure

SEC source: 0001127602-21-012565 · form4.xml · nonDerivative · entry 1

Schulten Andre · CIK 0001844763 · Chief Financial Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 24,278.196

F1 · shares: Shares sold to cover tax obligations upon settlement of Restricted Stock Unit Award.

Read SEC document
March 09, 2021 Filed Mar 10, 2021 18:53 UTC GrantCommon Stock 128 $0.00 $0.00
Disclosure

SEC source: 0001127602-21-010019 · form4.xml · nonDerivative · entry 1

Allen Bertrand Marc · CIK 0001632131 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 128

F1 · price: Restricted Stock Units awarded pursuant to The Procter & Gamble 2019 Stock and Incentive Compensation Plan.

Read SEC document
March 09, 2021 Filed Mar 10, 2021 18:55 UTC GrantCommon Stock 238 $0.00 $0.00
Disclosure

SEC source: 0001127602-21-010020 · form4.xml · nonDerivative · entry 1

Braly Angela F · CIK 0001321458 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 46,361.7748

F1 · price: Restricted Stock Units awarded pursuant to The Procter & Gamble 2019 Stock and Incentive Compensation Plan.

F2 · balance_after: Total includes grant of dividend equivalents in the form of Restricted Stock Units (RSU's) and shares acquired through the issuer's dividend reinvestment plan.

Read SEC document
March 09, 2021 Filed Mar 10, 2021 18:57 UTC GrantCommon Stock 199 $0.00 $0.00
Disclosure

SEC source: 0001127602-21-010021 · form4.xml · nonDerivative · entry 1

BLAKE FRANCIS S · CIK 0001194702 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 19,549.041

F1 · price: Common Stock awarded pursuant to The Procter & Gamble 2019 Stock and Incentive Compensation Plan

F2 · balance_after: Total includes grant of dividend equivalents in the form of Restricted Stock Units.

Read SEC document
March 09, 2021 Filed Mar 10, 2021 18:58 UTC
Chang AmyDirector
GrantCommon Stock 199 $0.00 $0.00
Disclosure

SEC source: 0001127602-21-010022 · form4.xml · nonDerivative · entry 1

Chang Amy · CIK 0001551504 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 7,677.508

F1 · price: Restricted Stock Units awarded pursuant to The Procter & Gamble 2019 Stock and Incentive Compensation Plan.

F2 · balance_after: Total includes grant of dividend equivalents in the form of Restricted Stock Units.

Read SEC document
March 09, 2021 Filed Mar 10, 2021 19:00 UTC GrantCommon Stock 238 $0.00 $0.00
Disclosure

SEC source: 0001127602-21-010023 · form4.xml · nonDerivative · entry 1

JIMENEZ JOSEPH · CIK 0001199095 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 21,524.194

F1 · price: Restricted Stock Units awarded pursuant to The Procter & Gamble 2019 Stock and Incentive Compensation Plan.

F2 · balance_after: Total includes grant of dividend equivalents in the form of Restricted Stock Units.

Read SEC document
March 09, 2021 Filed Mar 10, 2021 19:01 UTC GrantCommon Stock 248 $0.00 $0.00
Disclosure

SEC source: 0001127602-21-010024 · form4.xml · nonDerivative · entry 1

LUNDGREN TERRY J · CIK 0001184471 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 29,289.839

F1 · price: Restricted Stock Units awarded pursuant to The Procter & Gamble 2019 Stock and Incentive Compensation Plan.

F2 · balance_after: Total includes grant of dividend equivalents in the form of Restricted Stock Units (RSU's) and shares acquired through the issuer's dividend reinvestment plan.

Read SEC document
March 09, 2021 Filed Mar 10, 2021 19:02 UTC GrantCommon Stock 238 $0.00 $0.00
Disclosure

SEC source: 0001127602-21-010025 · form4.xml · nonDerivative · entry 1

McCarthy Christine M · CIK 0001332169 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 4,313.525

F1 · price: Restricted Stock Units awarded pursuant to The Procter & Gamble 2019 Stock & Incentive Compensation Plan.

F2 · balance_after: Total includes grant of dividend equivalents in the form of Restricted Stock Units.

Read SEC document
March 09, 2021 Filed Mar 10, 2021 19:03 UTC GrantCommon Stock 278 $0.00 $0.00
Disclosure

SEC source: 0001127602-21-010026 · form4.xml · nonDerivative · entry 1

MCNERNEY W JAMES JR · CIK 0001182055 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 84,785.565

F1 · price: Common Stock awarded pursuant to The Procter & Gamble 2019 Stock and Incentive Compensation Plan.

F2 · balance_after: Total includes grant of dividend equivalents in the form of Restricted Stock Units.

Read SEC document
March 09, 2021 Filed Mar 10, 2021 19:04 UTC GrantCommon Stock 298 $0.00 $0.00
Disclosure

SEC source: 0001127602-21-010027 · form4.xml · nonDerivative · entry 1

WOERTZ PATRICIA A · CIK 0001194945 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 36,913.15

F1 · price: Restricted Stock Units awarded pursuant to The Procter & Gamble 2019 Stock and Incentive Compensation Plan.

F2 · balance_after: Total includes grant of dividend equivalents in the form of Restricted Stock Units.

Read SEC document
February 26, 2021 Filed Feb 26, 2021 19:59 UTC
TASTAD CAROLYN MGroup Pres-Chief Sales Officer
SaleCommon Stock 1,219 $125.77 $153,315.34
Disclosure

SEC source: 0001127602-21-008051 · form4.xml · nonDerivative · entry 2

TASTAD CAROLYN M · CIK 0001597938 · Group Pres-Chief Sales Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 42,448.7086

F1 · shares: Shares sold to cover tax obligations upon settlement of Restricted Stock Unit award.

F2 · price: Weighted average price of the shares sold. The price range was $124.58 to $126.54. Full information regarding the number of shares sold at each separate price available upon request.

Read SEC document

Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.